Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM007310-006
Application #
3607925
Study Section
Project Start
1990-05-01
Project End
1996-11-30
Budget Start
1993-01-08
Budget End
1993-05-31
Support Year
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Ajani, J A (1997) Treatment of patients with upper gastrointestinal carcinomas. Semin Oncol 24:S19-72-S19-76
Legha, S S; Gianan, M A; Plager, C et al. (1996) Evaluation of interleukin-2 administered by continuous infusion in patients with metastatic melanoma. Cancer 77:89-96
Ajani, J A; Ilson, D H; Kelsen, D P (1996) Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas. Semin Oncol 23:55-8
Perez-Soler, R; Glisson, B S; Lee, J S et al. (1996) Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan. J Clin Oncol 14:2785-90
Ajani, J A; Ilson, D H; Kelsen, D P (1995) The activity of paclitaxel in gastrointestinal tumors. Semin Oncol 22:46-50;discussion 51-3
Daliani, D D; Eisenberg, P D; Weems, J et al. (1995) The results of a phase II randomized trial comparing 5-fluorouracil and 5-fluorouracil plus alpha-interferon: observations on the design of clinical trials for androgen-independent prostate cancer. J Urol 153:1587-91
Ajani, J A; Ilson, D H; Daugherty, K et al. (1995) Paclitaxel in the treatment of carcinoma of the esophagus. Semin Oncol 22:35-40
Pazdur, R; Bready, B; Scalzo, A J et al. (1994) Phase II trial of piroxantrone in metastatic gastric adenocarcinoma. Invest New Drugs 12:263-5
Pazdur, R; Moore, D F; Bready, B et al. (1994) Phase II trial of edatrexate in patients with advanced hepatocellular carcinoma. Ann Oncol 5:646-8
Moore Jr, D F; Pazdur, R; Abbruzzese, J L et al. (1994) Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma. Ann Oncol 5:286-7

Showing the most recent 10 out of 12 publications